Biotech Stock Intel
Catalyst CalendarPDUFA CalendarMover SignalsCompany Screener
Disclaimer: Biotech Stock Intel is an independent research platform. Information is provided for informational purposes only and is not investment or medical advice. Always verify catalyst dates against primary sources and conduct your own research.
Biotech Stock Intel© 2026 Biotech Stock Intel
AboutMethodologyTermsPrivacy
Biotech Stock Intel
Catalyst CalendarPDUFA CalendarMover SignalsCompany Screener
Home/Stocks/NXTC/Catalyst
Phase 1Update

SIM0505 (CDH6 ADC)

Advanced solid tumors

NXTCNextCure Inc
Expected catalystTBA

Catalyst overview

Event details

Drug or asset
SIM0505 (CDH6 ADC)
Development stage
Phase 1
Event type
Update
Indication
Advanced solid tumors

Research summary

What is being tracked?

This catalyst tracks a Phase 1 update for SIM0505 (CDH6 ADC) in Advanced solid tumors. The expected timing is based on the latest available company guidance and may change.

Development notes

08/06/26:- U.S. screening and enrollment stopped; no site expansion planned; SIM0505 value-preservation efforts continue.

Verification

Primary source

Confirm timing and program details against the company announcement or filing.

Open source

More from NXTC

Related pipeline programs

Phase 1

LNCB74 (B7-H4 ADC)

Solid tumor/s, Cancer, Ovarian cancer, Breast cancer, Endometrial cancer

View company pipeline

Company

NextCure Inc

NXTC · NasdaqGS
Industry
Biotechnology
Pipeline assets
7
View NXTC research

BioPharma Pro

Track every date change

Watchlists, source history and catalyst alerts will be available with Pro.

Start free

Updated Aug 23, 2026. Dates can change; this is not investment advice.

Disclaimer: Biotech Stock Intel is an independent research platform. Information is provided for informational purposes only and is not investment or medical advice. Always verify catalyst dates against primary sources and conduct your own research.
Biotech Stock Intel© 2026 Biotech Stock Intel
AboutMethodologyTermsPrivacy